ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 331 filers reported holding ASTRAZENECA PLC in Q3 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,194 | -5.4% | 121 | 0.0% | 0.00% | – |
| Q2 2023 | $8,660 | -38.1% | 121 | -41.5% | 0.00% | – |
| Q1 2022 | $14,000 | +366.7% | 207 | +276.4% | 0.00% | – |
| Q4 2021 | $3,000 | -50.0% | 55 | -51.3% | 0.00% | – |
| Q4 2020 | $6,000 | -78.6% | 113 | -81.8% | 0.00% | – |
| Q1 2020 | $28,000 | -99.2% | 620 | -99.1% | 0.00% | -100.0% |
| Q4 2019 | $3,607,000 | -40.3% | 72,345 | -46.6% | 0.02% | -46.9% |
| Q3 2019 | $6,042,000 | +11.0% | 135,538 | +2.8% | 0.03% | +10.3% |
| Q2 2019 | $5,443,000 | +2.7% | 131,854 | +0.5% | 0.03% | -3.3% |
| Q1 2019 | $5,302,000 | +7.2% | 131,137 | +0.7% | 0.03% | -11.8% |
| Q4 2018 | $4,948,000 | -49.6% | 130,282 | -47.5% | 0.03% | -40.4% |
| Q3 2018 | $9,815,000 | -21.6% | 248,053 | -30.5% | 0.06% | -28.8% |
| Q2 2018 | $12,525,000 | -4.4% | 356,725 | -4.8% | 0.08% | -18.4% |
| Q1 2018 | $13,101,000 | -8.5% | 374,620 | -9.2% | 0.10% | -15.5% |
| Q4 2017 | $14,315,000 | +3.2% | 412,535 | +0.8% | 0.12% | -7.2% |
| Q3 2017 | $13,865,000 | -1.0% | 409,246 | -0.4% | 0.12% | -10.7% |
| Q2 2017 | $14,001,000 | +6.7% | 410,688 | -2.5% | 0.14% | -2.1% |
| Q1 2017 | $13,117,000 | +36.6% | 421,250 | +19.8% | 0.14% | +25.4% |
| Q4 2016 | $9,604,000 | -22.1% | 351,556 | -6.3% | 0.11% | -26.0% |
| Q3 2016 | $12,332,000 | +748.1% | 375,301 | +679.3% | 0.15% | +600.0% |
| Q2 2016 | $1,454,000 | +10.8% | 48,157 | +3.4% | 0.02% | +4.8% |
| Q1 2016 | $1,312,000 | -18.6% | 46,586 | -1.9% | 0.02% | -22.2% |
| Q4 2015 | $1,612,000 | -0.7% | 47,495 | -6.9% | 0.03% | -3.6% |
| Q3 2015 | $1,624,000 | +19.6% | 51,024 | +139.4% | 0.03% | +33.3% |
| Q2 2015 | $1,358,000 | +134.5% | 21,316 | +151.9% | 0.02% | +133.3% |
| Q1 2015 | $579,000 | +19.6% | 8,462 | +23.0% | 0.01% | +12.5% |
| Q4 2014 | $484,000 | -59.7% | 6,877 | -59.1% | 0.01% | -61.9% |
| Q3 2014 | $1,202,000 | +47.1% | 16,823 | +53.0% | 0.02% | +50.0% |
| Q2 2014 | $817,000 | +1.1% | 10,996 | -11.7% | 0.01% | 0.0% |
| Q1 2014 | $808,000 | +63.6% | 12,453 | +49.6% | 0.01% | +75.0% |
| Q4 2013 | $494,000 | +121.5% | 8,322 | +93.9% | 0.01% | +100.0% |
| Q3 2013 | $223,000 | – | 4,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |